Targeted therapy of angiogenesis using anti-VEGFR2 and anti-NRP-1 nanobodies - Karami, Elmira; Naderi, Shamsi; Roshan, Reyhaneh; Behdani, Mahdi; Kazemi-Lomedasht, Fatemeh (Cancer chemotherapy and pharmacology, 2022)
Keywords: Angiogenesis; Angiogenesis Inhibitors - administration & dosage; Angiogenesis Inhibitors - pharmacology; Animals; Cancer Research; Cell proliferation; Cell Proliferation - drug effects; Chorioallantoic Membrane; Endothelial cells; HCT116 Cells; Human Umbilical Vein Endothelial Cells; Humans; Medicine; Medicine & Public Health; Mice; Mice, Nude; Molecular Targeted Therapy; Nanobodies; Neovascularization, Pathologic - therapy; Neuropilin; Neuropilin-1 - antagonists & inhibitors; Oncology; Original Article; Pharmacology/Toxicology; Single-Domain Antibodies - administration & dosage; Single-Domain Antibodies - pharmacology; Tumors; Vascular endothelial growth factor; Vascular endothelial growth factor receptor 2; Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors; Vascularization; VEGFR2; Nanobody; NRP-1; Combination therapy; Target therapy